They found that younger age, estrogen receptor (ER)-negative status, HER2-positive status, higher tumor stage, higher histologic grade (HG), large tumor size, and high Ki67 labeling index were independent risk factors for BCBM. The gene discussed is MKI67; the disease is neoplasm.